Literature DB >> 8579753

Immunosuppressive retroviral peptides: cAMP and cytokine patterns.

S Haraguchi1, R A Good, N K Day.   

Abstract

The mechanism(s) by which retroviral proteins exert immunosuppressive influences has remained enigmatic. Here, Soichi Haraguchi, Robert Good and Noorbibi Day propose that induction of intracellular cAMP by a synthetic, immunosuppressive, retroviral envelope peptide causes a shift in the cytokine balance, leading to suppression of cell-mediated immunity by upregulation of interleukin 10 (IL-10) and downregulation of IL-2, IL-12 and tumor necrosis factor alpha production. This may be a crucial step towards generation of immune dysfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8579753     DOI: 10.1016/0167-5699(95)80083-2

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  38 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

Review 2.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

3.  Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptors.

Authors:  Ester Sciaraffia; Antonella Riccomi; Ragnar Lindstedt; Valentina Gesa; Elisa Cirelli; Mario Patrizio; Maria Teresa De Magistris; Silvia Vendetti
Journal:  J Leukoc Biol       Date:  2014-03-20       Impact factor: 4.962

4.  Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis.

Authors:  D Pyeon; G A Splitter
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

5.  Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.

Authors:  H Y Dai; G I Troseth; M Gunleksrud; T Bruland; L A Solberg; H Aarset; L I Kristiansen; A Dalen
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Integration of calcium and cyclic AMP signaling pathways by 14-3-3.

Authors:  C W Chow; R J Davis
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

7.  Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients.

Authors:  R W Stevens; A L Baltch; R P Smith; B J McCreedy; P B Michelsen; L H Bopp; H B Urnovitz
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

8.  Norepinephrine-mediated suppression of phagocytosis by wound neutrophils.

Authors:  Ankush Gosain; Richard L Gamelli; Luisa A DiPietro
Journal:  J Surg Res       Date:  2008-06-02       Impact factor: 2.192

9.  Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells.

Authors:  E R Fedyk; R P Phipps
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Tumor cells expressing a retroviral envelope escape immune rejection in vivo.

Authors:  M Mangeney; T Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.